Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.70
-0.90 (-2.16%)
At close: Nov 17, 2026, 4:00 PM EST
40.67
-0.03 (-0.07%)
Pre-market: Nov 18, 2026, 4:25 AM EST

Novo Nordisk Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of $45.79. The average 1-year stock price forecast is 12.51% higher than the current stock price, while the lowest is $39.49 (-2.97%) and the highest is $64.16 (+57.64%).

Price Target: $45.79 (+12.51%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$39.49$45.79$43.57$64.16
Change-2.97%+12.51%+7.05%+57.64%

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy443333
Buy000000
Hold101011101010
Sell000000
Strong Sell000111
Total141414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BMO Capital
BMO Capital
Hold
Reiterates
$40 → $44
HoldReiterates$40 → $44+8.11%Nov 4, 2026
Berenberg Bank
Berenberg Bank
Hold
Maintains
$47
HoldMaintains$47+15.48%Oct 14, 2026
TD Cowen
TD Cowen
Hold
Maintains
$42
HoldMaintains$42+3.19%Sep 23, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Hold
Maintains
$42
HoldMaintains$42+3.69%Sep 22, 2026
Morgan Stanley
Morgan Stanley
Sell
Downgrades
$40
SellDowngrades$40-1.72%Sep 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
310.52B
from 309.06B
Increased by 0.47%
Revenue Next Year
313.51B
from 310.52B
Increased by 0.96%
EPS This Year
22.79
from 23.03
Decreased by -1.04%
EPS Next Year
22.57
from 22.79
Decreased by -0.98%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
140.80B176.95B232.26B290.40B309.06B310.52B
Revenue Growth
10.91%25.68%31.26%25.03%6.43%0.47%
Gross Profit
117.14B148.53B196.94B246.84B254.69B248.59B
Gross Margin
83.20%83.94%84.79%85.00%82.41%80.06%
Operating Income
59.22B75.62B104.70B138.90B140.62B126.84B
Net Income
47.76B55.53B83.68B100.99B102.43B101.86B
EPS
----23.0322.79
EPS Growth
----1.77%-1.04%
Forward PE
-----12.17
Dividend / Share
5.206.209.4011.4011.7011.36
Dividend Growth
14.29%19.23%51.61%21.28%2.63%-2.88%
Free Cash Flow
----58.96B67.86B
No. Analysts
-----27
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High337.7B
Avg310.5B
Low280.9B

Revenue Growth

Revenue Growth202620272028
High
9.3%
Avg
0.5%
Low
-9.1%

EPS Forecast

EPS202620272028
High26.99
Avg22.79
Low18.59

EPS Growth

EPS Growth202620272028
High
17.2%
Avg
-1.0%
Low
-19.3%